Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Delta tocotrienol in recurrent ovarian cancer. A phase II trial.
Thomsen CB, Andersen RF, Steffensen KD, Adimi P, Jakobsen A. Thomsen CB, et al. Among authors: adimi p. Pharmacol Res. 2019 Mar;141:392-396. doi: 10.1016/j.phrs.2019.01.017. Epub 2019 Jan 9. Pharmacol Res. 2019. PMID: 30639384 Free article. Clinical Trial.
Blood natural killer cells during treatment in recurrent ovarian cancer.
Henriksen JR, Nederby L, Donskov F, Waldstrøm M, Adimi P, Jakobsen A, Dahl Steffensen K. Henriksen JR, et al. Among authors: adimi p. Acta Oncol. 2020 Nov;59(11):1365-1373. doi: 10.1080/0284186X.2020.1791358. Epub 2020 Jul 21. Acta Oncol. 2020. PMID: 32692270
Carboplatin re-treatment in platinum-resistant epithelial ovarian cancer patients.
Hansen MKG, Smerdel MP, Waldstrøm M, Andersen RF, Adimi P, Jakobsen A, Steffensen KD. Hansen MKG, et al. Among authors: adimi p. Cancer Chemother Pharmacol. 2020 Dec;86(6):751-759. doi: 10.1007/s00280-020-04162-5. Epub 2020 Oct 16. Cancer Chemother Pharmacol. 2020. PMID: 33067703 Clinical Trial.
37 results